BioTech Pharma Summit

FUJIFILM Diosynth Biotechnologies is delighted to be presenting at BioTech Pharma Summit, November 29-30, 2021, Porto, Portugal.

Join us on November 29, 2021 at 8:30

Dr. Nick Hutchinson, Business Steering Group Leader for Mammalian Cell Culture at FUJIFILM Diosynth Biotechnologies is presenting on Antibody Manufacturing Strategies during a Pandemic

• The development of antibody therapeutics has been made even more challenging as a consequence of the COVID-19 pandemic. Development and manufacturing capacity around the world has seen a surge in demand and companies attempt to bring new COVID-19 treatments and vaccines to patients and help resolve the crisis.
• Poorly judged steps during the development of manufacturing strategies can have a devastating impact on the commercial success of antibody products and must be avoided. Adopting platform processes and methods can save time and cost during development but will not necessarily be appropriate for novel antibody formats, such as multi-specific antibodies, where a more nuanced approach might be more applicable.
• Choosing between scale-up, scale-out or even continuous biomanufacturing options can be a minefield to navigate during late-phase development or before, yet can significantly impact the risk profile of programmes with uncertain demand forecasts and mounting competition. This presentation will explain how to develop an antibody manufacturing strategy during this global pandemic.

For the agenda and registration click here